Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury

Journal of Immunology

Volumn 178, Issue 12, 2007, Pages 8127-8137

  Eckle, Tobias ^a   Füllbier, Lars ^a   Wehrmann, Manfred ^a   Khoury, Joseph ^b   Mittelbronn, Michel ^a   Ibla, Juan ^b   Rosenberger, Peter ^a   Eltzschig, Holger K ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; APYRASE; CD39 ANTIGEN; ECTO 5' NUCLEOTIDASE;

ACUTE LUNG INJURY; ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE SEVERITY; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; LUNG EDEMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 34250155915     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.12.8127     Document Type: Article

References (42)

1. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349.
2. Rubenfeld, G. D., E. Caldwell, E. Peabody, J. Weaver, D. P. Martin, M. Neff, E. J. Stern, and L. D. Hudson. 2005. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353: 1685-1693.
3. Thiel, M., A. Chouker, A. Ohta, E. Jackson, C. Caldwell, P. Smith, D. Lukashev, I. Bittmann, and M. V. Sitkovsky. 2005. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3: e174.
4. Martin, T. R. 2002. Neutrophils and lung injury: getting it right. J. Clin. Invest. 110: 1603-1605.
5. Licker, M., M. de Perrot, A. Spiliopoulos, J. Robert, J. Diaper, C. Chevalley, and J. M. Tschopp. 2003. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth. Analg. 97: 1558-1565.
6. Milot, J., J. Perron, Y. Lacasse, L. Letourneau, P. C. Cartier, and F. Maltais. 2001. Incidence and predictors of ARDS after cardiac surgery. Chest 119: 884-888.
7. Shorr, A. F., K. C. Abbott, and L. Y. Agadoa. 2003. Acute respiratory distress syndrome after kidney transplantation: epidemiology, risk factors, and outcomes. Crit. Care Med. 31: 1325-1330.
8. Liedtke, C. M., X. Wang, and N. D. Smallwood. 2005. Role for protein phosphatase 2A in the regulation of Calu-3 epithelial Na+-K+-2Cl-, type 1 co-transport function. J. Biol. Chem. 280: 25491-25498.
9. Eltzschig, H. K., J. C. Ihla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796.
10. Birukov, K. G., J. R. Jacobson, A. A. Flores, S. Q. Ye, A. A. Birukova, A. D. Verin, and J. G. Garcia. 2003. Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch. Am. J. Physiol. 285: L785-L797.
11. Eltzschig, H. K., M. Faigle, S. Knapp, J. Karhausen, J. Ihla, P. Rosenberger, K. C. Odegard, P. C. Laussen, L. F. Thompson, and S. P. Colgan. 2006. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108: 1602-1610.
12. Eltzschig, H. K., P. Abdulla, E. Hoffman, K. E. Hamilton, D. Daniels. C. Schonfeld, M. Loffler, G. Reyes, M. Duszenko, J. Karhausen, et al. 2005. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202: 1493-1505.
13. Grenz, A., H. Zhang, T. Eckle, M. Mittelbronn, M. Wehrmann, C. Kohle, D. Kloor, L. F. Thompson, H. Osswald, and H. K. Eltzschig. 2007. Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J. Am. Soc. Nephrol. 18: 833-845.
14. Lennon, P. F., C. T. Taylor, G. L. Stahl, and S. P. Colgan. 1998. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188: 1433-1443.
15. Thompson, L. F., H. K. Eltzschig, J. C. Ibla, C. J. Van De Wiele, R. Resta, J. C. Morote-Garcia, and S. P. Colgan. 2004. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200: 1395-1405.
16. Enjyoji, K., J. Sevigny, Y. Lin, P. S. Frenette, P. D. Christie, J. S. Esch, 2nd, M. Imai, J. M. Edelberg, H. Rayburn, M. Lech, et al. 1999. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5: 1010-1017.
17. Eckle, T., T. Krahn, A. Grenz, D. Kohler, M. Mittelbronn, C. Ledent, M. A. Jacobson, H. Osswald, L. F. Thompson, K. Unertl, and H. K. Eltzschig. 2007. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590.
18. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45.
19. Speyer, C. L., N. J. Rancilio, S. D. McClintock, J. D. Crawford, H. Gao, J. V. Sarma, and P. A. Ward. 2005. Regulatory effects of estrogen on acute lung inflammation in mice. Am. J. Physiol. 288: C881-C890.
20. Graff, G., D. A. Gamache, M. T. Brady, J. M. Spellman, and J. M. Yanni. 1998. Improved myeloperoxidase assay for quantitation of neutrophil influx in a rat model of endotoxin-induced uveitis. J. Pharmacol. Toxicol. Methods 39: 169-178.
21. Schneider, T. and A. C. Issekutz. 1996. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase: application in a Brown Norway rat model of allergic pulmonary inflammation. J. Immunol. Methods 198: 1-14.
22. Belperio, J. A., M. P. Keane, M. D. Burdick, V. Londhe, Y. Y. Xue, K. Li, R. J. Phillips, and R. M. Strieter. 2002. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110: 1703-1716.
23. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. E. Thompson, and S. P. Colgan. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
24. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
25. Eltzschig, H. K., L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992.
26. Hasko, G., and B. N. Cronstein. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33-39.
27. Sitkovsky, M. V., D. Lukashev, S. Apasov, H. Kojima, M. Koshiba, C. Caldwell, A. Ohta, and M. Thiel. 2004. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22: 657-682.
28. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-eoupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
29. Kong, T., K. A. Westerman, M. Faigle, H. K. Eltzschig, and S. P. Colgan. 2006. HIF-dependent induction of adenosine A2B receptor in hvpoxia. FASEB J. 20: 2242-2250.
30. Gerasimovskaya, E. V., S. Ahmad, C. W. White, P. L. Jones, T. C. Carpenter, and K. R. Stenmark. 2002. Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. J. Biol. Chem. 277: 44638-44650.
31. Ahmad, S., A. Ahmad, M. Ghosh, C. C. Feslie, and C. W. White. 2004. Extracellular ATP-mediated signaling for survival in hyperoxia-induced oxidative stress. J. Biol. Chem. 279: 16317-16325.
32. Ahmad, S., A. Ahmad, G. McConville, B. K. Schneider, C. B. Allen, R. Manzer, R. J. Mason, and C. W. White. 2005. Lung epithelial cells release ATP during ozone exposure: signaling for cell survival. Free Radic. Biol. Med. 39: 213-226.
33. Novak, I. 2003. ATP as a signaling molecule: the exocrine focus. News Physiol. Sci. 18: 12-17.
34. Eltzschig, H. K., T. Eckle, A. Mager, N. Kuper, C. Karcher, T. Weissmuller, K. Boengler, R. Schulz, S. C. Robson, and S. P. Colgan. 2006. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ. Res. 90: 1100-1108.
35. Volmer, J. B., L. F. Thompson, and M. R. Blackburn. 2006. Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J. Immunol. 176: 4449-4458.
36. Chunn, J. L., J. G. Molina, T. Mi, Y. Xia, R. E. Kellems, and M. R. Blackburn. 2005. Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J. Immunol. 175: 1937-1946.
37. Sun, C.-X., H. W. Young, J. G. Molina, J. B. Volmer, J. Schnermann, and M. R. Blackburn. 2005. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J. Clin. Invest. 115: 35-43.
38. 2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116: 2173-2182.
39. Driver, A. G., C. A. Kukoly, S. Ali, and S. J. Mustafa. 1993. Adenosine in bronchoalveolar lavage fluid in asthma. Am. Rev. Respir. Dis. 148: 91-97.
40. Huszar, E., G. Vass, E. Vizi, Z. Csoma, E. Barat, G. Molnar Vilagos, I. Herjavecz, and I. Horvath. 2002. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur. Respir. J. 20: 1393-1398.
41. Fozard, J. R., and J. P. Hannon. 1999. Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. Pulm. Pharmacol Ther. 12: 111-114.
42. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192: 159-170.